Press release
Partial Epilepsy Market to Reach USD 9.36 Billion by 2034
Partial Epilepsy Market
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72067
Market Summary
The Partial Epilepsy Market is expanding steadily as physicians adopt newer anti-seizure medications, precision diagnostics, and minimally invasive neuromodulation treatments for patients with focal epilepsy. Partial epilepsy-characterized by seizures originating from a specific brain region-accounts for the majority of epilepsy cases globally. While traditional AEDs remain widely used, demand is increasing for next-generation therapies offering better seizure control, fewer side effects, and improved tolerability, including brivaracetam, lacosamide, cenobamate, perampanel, and long-acting formulations.
Diagnostic improvements such as high-resolution MRI, PET/SPECT imaging, video EEG, and AI-based seizure pattern analysis are enabling earlier and more accurate diagnosis. For drug-resistant cases, vagus nerve stimulation (VNS), deep brain stimulation (DBS), responsive neurostimulation (RNS), and laser ablation are gaining traction. North America leads the market, while Asia-Pacific is emerging rapidly due to rising awareness and expanding epilepsy treatment centers.
Key Takeaways
• 2024 Market Size: USD 5.84 Billion
• 2034 Forecast: USD 9.36 Billion
• CAGR: 4.8% (2025-2034)
• Newer anti-seizure medications driving treatment advancements
• Neuromodulation therapies gaining adoption for drug-resistant epilepsy
• Asia-Pacific showing strong growth due to expanding diagnostic capabilities
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72067/partial-epilepsy-market
Market Drivers
• Rising global prevalence of epilepsy, especially focal seizures
• Expanding portfolio of effective and better-tolerated anti-seizure medications
• Advancements in neurodiagnostics and seizure-monitoring systems
• Increased adoption of RNS, VNS & DBS for refractory epilepsy
• Growing awareness and improved access to specialized epilepsy centers
Segmentation Snapshot
By Drug Class
• Sodium Channel Blockers
• SV2A Ligands (Brivaracetam, Levetiracetam)
• GABA Modulators
• AMPA Antagonists
• Mixed-Mechanism AEDs
• Others
By Treatment
• Anti-Seizure Medications (Primary Share)
• Neuromodulation Therapies (VNS, DBS, RNS)
• Surgical Interventions
• Supportive & Psychological Care
By Diagnostic Method
• MRI & CT Imaging
• EEG & Video EEG
• PET/SPECT
• Neurophysiological Monitoring
• AI-Based Seizure Detection Tools
By End User
• Hospitals
• Neurology Clinics
• Epilepsy Treatment Centers
• Home Care
• Research Institutions
By Region
• North America (Largest Market)
• Europe
• Asia-Pacific (Fastest Growing)
• Latin America
• Middle East & Africa
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72067
Recent Developments
• Cenobamate showing strong outcomes in drug-resistant partial epilepsy.
• AI-based EEG interpretation tools gaining FDA clearance.
• Growth in minimally invasive laser ablation procedures.
• Expanded reimbursement for neuromodulation devices.
Expert Quote - Irfan Tamboli, Business Development Executive
"Breakthrough medications and advanced neuromodulation technologies are significantly improving seizure control for partial epilepsy patients. Earlier diagnosis and precision treatment strategies are shaping the future of epilepsy care."
Conclusion
The Partial Epilepsy Market will continue to grow through 2034 as innovative anti-seizure drugs, advanced neuroimaging technologies, and neuromodulation therapies enhance treatment outcomes. Companies investing in precision medicine, AI diagnostics, and next-generation AEDs will drive the future landscape.
This report is also available in the following languages : Japanese (部分てんかん市場), Korean (부분 간질 시장), Chinese (部分性癫痫市场), French (Marché de l'épilepsie partielle), German (Markt für partielle Epilepsie), and Italian (Mercato dell'epilessia parziale), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72067
Our More Reports:
Intracranial Pressure Monitoring Devices Market
https://exactitudeconsultancy.com/reports/72113/intracranial-pressure-monitoring-devices-market
Migraine Market
https://exactitudeconsultancy.com/reports/72115/migraine-market
Sacral Nerve Stimulation Devices Market
https://exactitudeconsultancy.com/reports/72117/sacral-nerve-stimulation-devices-market
Transcranial Doppler Market
https://exactitudeconsultancy.com/reports/72119/transcranial-doppler-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Partial Epilepsy Market to Reach USD 9.36 Billion by 2034 here
News-ID: 4303172 • Views: …
More Releases from Exactitude Consultancy
Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market to Reach USD 1 …
Pune, India - December 2025 - The global Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market, valued at USD 6.84 billion in 2024, is projected to reach USD 19.42 billion by 2034, growing at a robust 11.0% CAGR (2025-2034), according to Exactitude Consultancy. Rapid advancements in AAV-based gene therapies, antisense oligonucleotides (ASOs), RNA-targeting technologies, and improved diagnostic pathways are driving strong market momentum.
Download Full PDF Sample Copy of Market…
Prediabetes Market to Reach USD 29.84 Billion by 2034 Driven by Rising Global Di …
Pune, India - December 2025 - The global Prediabetes Market, valued at USD 14.62 billion in 2024, is projected to reach USD 29.84 billion by 2034, growing at a 7.2% CAGR (2025-2034), according to Exactitude Consultancy. The rising prevalence of insulin resistance, sedentary lifestyles, obesity, and increased screening initiatives are fueling substantial market growth.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72063
Market Summary
The Prediabetes Market is expanding rapidly as healthcare…
Pouchitis Market to Reach USD 1.12 Billion by 2034
Pune, India - December 2025 - The global Pouchitis Market, valued at USD 612.4 million in 2024, is projected to reach USD 1.12 billion by 2034, growing at a 6.1% CAGR (2025-2034), according to Exactitude Consultancy. Increasing incidence of ulcerative colitis requiring ileal pouch-anal anastomosis (IPAA) surgery, alongside advancements in anti-inflammatory, antibiotic, and microbiome-targeted therapies, are fueling market expansion.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72061
Market Summary
The Pouchitis Market…
Pituitary Stalk Interruption Syndrome (PSIS) Market to Reach USD 52.8 Million by …
Pune, India - December 2025 - The global Pituitary Stalk Interruption Syndrome (PSIS) Market, valued at USD 27.6 million in 2024, is projected to reach USD 52.8 million by 2034, growing at a 6.7% CAGR (2025-2034), according to Exactitude Consultancy. Improvements in MRI-based diagnosis, rising awareness among pediatric endocrinologists, and increased adoption of long-acting hormone therapies are supporting market expansion.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72059
Market Summary
The PSIS…
More Releases for Partial
Partial Discharge Measurement Camera | SM Instruments
SM Instruments provides a fixed outdoor partial discharge camera for detecting gas leaks and faults. It performs well even in harsh, wet, or cold environments.
SM Instruments BATCAM FX
Fixed Ultrasonic Acoustic Camera for Outdoor Gas Leak and Partial Discharge Detection
The BATCAM FX is a fixed ultrasonic camera designed for continuous outdoor monitoring of gas leaks, electrical faults, and partial discharges, even in harsh environments such as cold, wet, or noisy industrial…
Partial Hospitalization Program Treatment
When it comes to addiction treatment, there are different levels of care. These levels of care vary depending on how intense the patient’s addiction is. These levels of care also vary based on structure intensity. For example, individuals that suffer from severe addictions will need to receive care through inpatient or residential treatment programs. The next most intensive and structured form of addiction treatment after inpatient and residential treatment is…
Ultrasonic Camera for Partial Discharge Detection| SM INSTRUMENTS
Specialized Ultrasonic Camera BACTAM for partial discharge detection is available in SM Instruments Inc.
SM Instruments is a Gold Alliance Partner of the National Instruments of the US since its foundation in 2006. The main technologies of SM Instruments are visualization of sound using the sound camera, and detection of Buzz, Squeak, and Rattle using BSR Tools.
What is the Partial discharge
Partial discharge (PD) is a localized dielectric breakdown of a…
Activated Partial Thromboplastin Market Overview by 2020-2026
Scope of the Report:
The worldwide market for Activated Partial Thromboplastinis expected to grow at a CAGR of roughly x% over the next five years, will reach x million US$ in 2024, from x million US$ in 2019, according to a new Global Info Researchstudy.
The report presents the market outlook for the Indian Phospho Gypsum product from the year 2019 to the year 2025. The report provides a definition of the…
Components of full or partial automatic stripping machine
1. The principle of work for full or partial automatic stripping machine:
Transmission wire through inlet wire wheel and outlet wire wheel and complete the cutting and stripping with knife rest assembly.
2. Brief introduction to main components function:
(1) Inlet wire wheel uplift knob: uplift inlet wire wheel while full or partial automatic stripping machine‘s threading, turn the knob clockwise to raise up inlet wire wheel, so that you can smoothly pass…
Trends and Forecast Update on Point-of-Care Partial Thromboplastin Time and Acti …
Point of care Partial Thromboplastin Time (PTT) and Activated Partial Thromboplastin Time (APTT) testing are majorly performed at the patient’s site. It provides rapid tests for the tests such as partial thromboplastin and activated partial thromboplastin as compared to other laboratory testing techniques. In addition, point of care offers immediate and convenient patient diagnosis option. Partial thromboplastin time test is primarily used to measure the blood clotting time of the…
